Method for the intranasal administration of 3-[2-(dimethylamino)-ethyl]-H-methyl-1H-indole-5-methanesulphonamide
Patent 5393773 Issued on February 28, 1995. Estimated Expiration Date: 
July 12, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
July 12, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsAssigneeApplicationNo. 084235 filed on 07/12/1993US Classes:514/415The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.)ExaminersPrimary: Henley, III, RaymondAssistant: Criares, T. J. Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/405Foreign Application Priority Data1991-01-24 GBAbstractA method of treating a human suffering from or susceptable to cephalic pain by intramasally administering 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indol-5-methanesulphonamide in a pH range of from 9-11. | |
